Gumikas, Samia .
HRN: 22-22-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/14/2023
02/15/2023
IV
500mg
Q 8hrs X 3 Doses
Thicky MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes